COBIMETINIB for Transitional cell carcinoma: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

There are 6 adverse event reports in the FDA FAERS database where COBIMETINIB was used for Transitional cell carcinoma.

Most Reported Side Effects for COBIMETINIB

Side Effect	Reports	%	Deaths	Hosp.
Diarrhoea	412	10.1%	39	214
Off label use	411	10.1%	40	65
Rash	369	9.1%	11	166
Pyrexia	332	8.2%	19	228
Death	231	5.7%	230	23
Nausea	206	5.1%	17	105
Fatigue	198	4.9%	15	93
No adverse event	178	4.4%	0	1
Vomiting	168	4.1%	20	108
Acute kidney injury	133	3.3%	18	114
Photosensitivity reaction	124	3.1%	10	44
Asthenia	119	2.9%	13	68
Rash maculo-papular	118	2.9%	7	73
Blood creatine phosphokinase increased	114	2.8%	5	58
Drug reaction with eosinophilia and systemic symptoms	113	2.8%	6	72